mTOR inhibitor-independent Autophagy Activator Ameliorates Cellular Tauopathy and Prionopathy Neurodegeneration Phenotypes
Yoon, L.; Botham, R. C.; Verhelle, A.; Cole, C.; Tan, E. P.; Wu, Y.; Sanz-Martinez, P.; Xu, J.; Cuoco, C. A.; Chou, C. C.; Labra, S.; Elia, L. P.; Massey, L. A.; Lee, K.; Xiao, Q.; Kline, G. M.; Ta, A.; Ardejani, M. S.; Cano-Franco, S.; Lyang, N. J.; Hou, W. C.; Yu, A.; Fox, S.; Ko, Y.; Chen, W.; Wulkop-Gil, C.; Ibrahim, L. H.; Jiang, S.; Meneses, A.; Nelson, L. T.; Peng, H.; Lipton, S. A.; Bollong, M. J.; Hansen, M.; Morimoto, R. I.; Finley, D.; Petrassi, H. M.; Wiseman, R. L.; Powers, E. T.; Finkbeiner, S.; Garza, D.; Prado, M. A.; Dikic, I.; Frydman, J.; Johnson, K. A.; Silva, M. C.; Haggar
Show abstract
Autophagy-lysosomal impairment is an early and prominent feature of neurodegeneration. Autophagy activation reduces protein aggregates and lipid level abnormalities. We performed a high-content imaging-based screen assessing 940,000 small molecules to identify those that reduce lipid droplet numbers. Of 77 validated, structurally diverse hits, 24 increased autophagy flux reporter activity, consistent with accelerated lipid droplet clearance by lipophagy. Of these, we show that CCT020312 activates autophagy independently of mammalian target of rapamycin (mTOR) inhibition, to avoid immunosuppression. CCT020312 reduced insoluble phosphorylated tau levels and tau-mediated neuronal stress vulnerability, as well as reducing intracellular A{beta} levels within directly induced neurons bearing epigenetic marks of aging derived from Alzheimers patient fibroblasts. Moreover, CCT020312 cleared mutant prion protein aggregates and normalized trafficking deficiencies in axons of a cellular model of familial prion disease. Autophagy is widely considered a promising strategy to attenuate neurodegeneration, and here we introduce a strategy to discover new pharmacology.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- The Glycolytic Metabolite Methylglyoxal Covalently Inactivates the NLRP3 Inflammasome. 95%
- Tau assemblies enter the cytosol in a cholesterol sensitive process essential to seeded aggregation 95%
- Drug-induced eRF1 degradation promotes readthrough and reveals a new branch of ribosome quality control 95%
Similar papers in this journal
- Obtusaquinone is a cysteine modifying compound that targets Keap1 for degradation 95%
- In vivo prenylomic profiling in the brain of a transgenic mouse model of Alzheimer's disease reveals increased prenylation of a key set of proteins 95%
- Novel Lipophagy Inducers as Potential Therapeutics for Lipid Metabolism Disorders 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.